Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
NCT04052698
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Von Willebrand Diseases
Interventions
DRUG:
Wilate
Sponsor
Octapharma